Gagandeep, S <br/><br/>
Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect".  [electronic resource] 

 -  Cancer gene therapy   
 - 83-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0929-1903 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--immunology<br/>Animals<br/>CD4-CD8 Ratio<br/>Colonic Neoplasms--immunology<br/>Down-Regulation<br/>Female<br/>Ganciclovir--therapeutic use<br/>Genetic Therapy--methods<br/>Genetic Vectors--administration & dosage<br/>Immune Tolerance--immunology<br/>Immunohistochemistry<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Phenotype<br/>Prodrugs--therapeutic use<br/>Simplexvirus--drug effects<br/>Statistics, Nonparametric<br/>Thymidine Kinase--genetics<br/>Tumor Cells, Cultured